Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Lu-Tex clinical update

April 5, 1996

New antitumor proteins from Alfacell

April 5, 1996

Oncogene Science, Pfizer extend research agreement

April 5, 1996

New telomerase inhibitor from Geron

April 5, 1996

Kyowa Hakko discloses UCF76-B

April 5, 1996

Regeneron investigates Tie-2 ligand

April 5, 1996

New angiogenesis inhibitors from ADIR

April 5, 1996

PD-145709: New tyrosine kinase inhibitor from Warner-Lambert

April 5, 1996

SU-101 designated orphan drug

April 5, 1996

Merck & Co. reports farnesyl transferase inhibitors

April 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...